Hans Dahlin

Title: Innovations by Hans Dahlin in Drug Concentration Evaluation

Introduction

Hans Dahlin is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of medical technology, particularly in the evaluation of drug concentrations in body fluids. His innovative approach has the potential to enhance the accuracy of drug monitoring in clinical settings.

Latest Patents

Hans Dahlin holds a patent for a method and system for evaluating drug concentration in blood, plasma, or serum. This patent outlines a comprehensive method that includes preparing body fluid samples by removing unsolved components, performing absorption spectrophotometric analyses, and evaluating drug concentrations based on these analyses. This innovative method aims to improve the reliability of drug concentration assessments in various medical applications. He has 1 patent to his name.

Career Highlights

Dahlin is associated with Raysearch Laboratories AB, where he applies his expertise in medical technology. His work focuses on developing advanced solutions that facilitate better patient care through improved drug monitoring techniques. His contributions have been instrumental in advancing the capabilities of medical diagnostics.

Collaborations

Hans collaborates with Jörgen Höjdmo, working together to enhance the research and development efforts at Raysearch Laboratories AB. Their combined expertise fosters innovation and drives the development of cutting-edge medical technologies.

Conclusion

Hans Dahlin's work in evaluating drug concentrations represents a significant advancement in medical technology. His innovative methods have the potential to improve patient outcomes through more accurate drug monitoring. His contributions to the field are noteworthy and continue to influence the landscape of medical diagnostics.